The Fischer group is focussed on the development of natural and synthetic micro- and nanocarriers for drug delivery in the field of infection, inflammation and inflammation-related diseases as well as aging. A major focus is related to biopharmaceutical test systems according to the 3R principle to investigate the life cycle of drug delivery systems and the influence of the physiological environment. Furthermore, nanosafety and safe-by-design concepts as well as quality assurance concepts are provided
New research published presenting a new formulation technique for PLGA particles using the renewable solvent Cyrene TM:
Cyrene als Alterantive Sustainable Solvent for the Preparation of Poly(lactic-co-glycolic acid) Nanoparticles - Sciencedirect News — Circa Group (circa-group.com)Continue
Prof. Dr. Dagmar Fischer wurde am 10.7.2021 in der renommierten Wissenschaftsakademie „Akademie für gemeinnützige Wissenschaften zu Erfurt“ als ordentliches Mitglied mit Sitz und Stimme in der Mathematisch-Naturwissenschaftlichen Klasse ernannt.
Ula received the Student Poster Award at the 20th Annual International Symposium for Therapeutic Ultrasound in Korea with her poster entiteled 'Investigation of Sonosensitive PLGA and PEG-PLGA Nanocapsules for Drug Delivery with Use of Focussed Ultrasound'.Continue
The 13th German edition of the Voigt's „Pharmazeutische Technologie“, an interdisciplinary textbook covering the fundamental principles of pharmaceutical technology, is now available, under the contribution of Prof. Fischer as author of several chapters.Continue
Am Lehrstuhl für Pharmazeutische Technologie der Friedrich-Alexander-Universität Erlangen-Nürnberg ist zum nächstmöglichen Zeitpunkt in der „F...Continue
On the 21st of May 2019 the students attending the practical courses this semester had a good chance to get in touch with the daily processes in the pharmaceutical industry at Dr. Pfleger in Bamberg. This included a guided tour through the departments packaging, production and quality control. Addit...Continue
